Invivogen
Menu

IL-22 Reporter HEK 293 Cells

HEK-Blue™ IL-22 Cells Unit size Cat. code Docs Qty Price
Human & Mouse IL-22 Reporter Cells
3-7 x 10e6 cells
hkb-il22
+-
$1,304.00

You may also need : QUANTI-Blue™ | View more associated products

IL-22 Reporter Cells

HEK-Blue IL-22 Cells signaling pathway
HEK-Blue™ IL-22 Cells signaling pathway

HEK-Blue™ IL-22 cells were engineered from the human embryonic kidney HEK293 cell line to detect bioactive human and murine IL-22 by monitoring the activation of the STAT3 pathway. These cells can also be used for screening anti-IL-22 antibodies.

Interleukin 22 (IL-22) is a key regulator of immunity and inflammation at mucosal surfaces where it helps in maintaining barrier integrity [1-3]. 

More More details

 

Cell line description:

HEK-Blue™ IL-22 cells were generated by stable transfection of HEK293 cells with the human genes for IL-22 receptor (IL-22R1 and IL-10Rβ),  STAT3, and a STAT3-inducible SEAP (secreted embryonic alkaline phosphatase) reporter. Binding of IL-22 to its receptor on the surface of HEK-Blue™ IL-22 cells triggers a signaling cascade leading to the activation of STAT3, and the subsequent production of SEAP.  For your convenience, InvivoGen provides QUANTI‑Blue™ Solution, an easy and rapid means to detect and quantify SEAP activity in the cell culture supernatant.  

Features of HEK-Blue™ IL-22 cells:

  • Fully functional IL-22 signaling pathway
  • Readily assessable SEAP reporter activity
  • Functionally tested
  • Guaranteed mycoplasma-free

Applications of HEK-Blue™ IL-22 cells:

  • Detection of both human and murine IL-22
  • Screening of anti-IL-22 antibodies

 

References:

1. Wang J.et al., 2018. Aryl hydrocarbon receptor/IL-22/Stat3 signaling pathway is involved in the modulation of intestinal mucosa antimicrobial molecules by commensal microbiota in mice. Innate Immun. 24(5):297-306.
2. Foxall R.B. et al.., 2016. Profile of interleukin-22 in gut mucosal health and disease. IJICMR. 8:1-11. 
3. Park J.H. et al., 2017. There Is a Gap in Our Knowledge. Immunohorizons. 2(6):198-207. 

Figures

Evaluation of IL-22 response in HEK-Blue™ IL-22 Cells
Evaluation of IL-22 response in HEK-Blue™ IL-22 Cells

Dose-response of HEK-Blue™ IL-22 cells to recombinant IL-22.

Cells were stimulated with increasing concentrations of recombinant human or murine IL-22. After overnight incubation, the STAT3 response was determined using QUANTI‑Blue™ Solution, a SEAP detection reagent, and reading the optical density (OD) at 630 nm. EC50 values are shown as mean ± SD.

Evaluation of specificity in HEK-Blue™ IL-22 Cells
Evaluation of specificity in HEK-Blue™ IL-22 Cells

Cytokine response of HEK-Blue™ IL-22 cells.

Cells were stimulated with various human and murine recombinant cytokines: 1 ng/ml of hIL‑22, mIL-22, hIL‑2, hIL-6, hIL-10, hIL-27, hIL-28A, hIL-28B, hIL-29, hTNF-α, 1x103 hIFN-β. After overnight incubation, SEAP activity was assessed using QUANTI‑Blue™ Solution. 

Evaluation of IL-22 inhibition in HEK-Blue™ IL-22 Cells
Evaluation of IL-22 inhibition in HEK-Blue™ IL-22 Cells

Dose-dependent inhibition of HEK‑Blue™ IL-22 cellular response using a neutralizing antibody against the IL-22 receptor (IL‑22R).

The antibody was incubated with HEK‑Blue™ IL-22 cells for 30 minutes prior to the addition of hIL-22 (10 ng/ml). After overnight incubation, SEAP activity in the cell culture supernatant was assessed using QUANTI‑Blue™ Solution. Data represent % inhibition of reporter activity without the anti‑IL-22R antibody.

Back to the top

Specifications

Antibiotic resistance: Blasticidin, PuromycinZeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2-4 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Specificity: human and mouse IL-22

Detection range:

  • 0.03 - 10 ng/ml for human IL-22
  • 0.1 - 10 ng/ml for murine IL-22

 

These cells are covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

Dry Ice Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top

Details

Interleukin 22 (IL-22) is a key regulator of immunity and inflammation at mucosal surfaces where it helps in maintaining barrier integrity [1-3]. IL-22 production can be triggered by a variety of pathogen-associated molecular patterns (PAMPs). Notably, it can be induced directly by Toll-like receptor 2 (TLR2) activation in response to bacterial-derived agonists, or indirectly via IL-23 in response to aryl-hydrocarbon receptor (AhR) ligands [1, 2]. IL-22 is implicated in a number of pathologies including autoimmune diseases and cancer [3, 4].  

IL-22 exerts its biological effect upon binding to its receptor, which comprises two subunits: IL-22R1 and IL-10Rβ. Upon binding, IL-22 triggers a signaling pathway involving tyrosine kinase 2 (TyK2) and Janus kinase 1 (JAK1) leading to the activation of signal transducer and activator of transcription 3 (STAT3). 

 

1. Wang J.et al., 2018. Aryl hydrocarbon receptor/IL-22/Stat3 signaling pathway is involved in the modulation of intestinal mucosa antimicrobial molecules by commensal microbiota in mice. Innate Immun. 24(5):297-306.
2. Foxall R.B. et al.., 2016. Profile of interleukin-22 in gut mucosal health and disease. IJICMR. 8:1-11. 
3. Park J.H. et al., 2017. There Is a Gap in Our Knowledge. Immunohorizons. 2(6):198-207. 
4. Hernandez P. et al., 2018. A catch-22: Interleukin-22 and cancer. Eur J Immunol. 48(1):15-31.

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty